Charnwood Molecular is celebrating another award nomination, having been shortlisted in the “Export Achievement” Category for the 2018 Medilink East Midlands Business Awards.
The company’s exports continue to grow apace, with international clients using Charnwood Molecular’s services in medicinal chemistry, research, development and synthesis.
Professor Steve Allin, Managing Director of Charnwood Molecular, was delighted with news of the award nomination: “In the year of our twentieth anniversary as a company, this nomination is testament to the hard work and commitment of the entire team at Charnwood Molecular. We have seen significant expansion of our global client base in recent years and this nomination recognises our team’s collective efforts in our drive to achieving excellence in our services.”
The aim of the awards is to highlight the best of the best in the Life Sciences sector for the East Midlands.
The Awards will be presented to East Midlands businesses who work in, service or supply to the Life Sciences, Healthcare, Medical Technology, Digital Health, Pharmaceutical & Biotechnology sectors.
The results of the award will be announced on the 13th June, at an all-day Medilink event taking place at the Nottingham Belfry.